Dan Raz is a Cardiology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 249 publications with 7,923 citations (h-index 43); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
Sponsor: City of Hope Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
1 NIH research award on record, funded 2021–2022 per NIH RePORTER. The latest:
- Effects of tumor-microbial interactions on EGFR-targeted therapy resistance in lung cancer
Beckman Research Institute/city of Hope
FY2022$201,587R21CA263751 - Effects of tumor-microbial interactions on EGFR-targeted therapy resistance in lung cancer
Beckman Research Institute/city of Hope
FY2021$246,840R21CA263751
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025
Journal of the National Comprehensive Cancer Network
2025 - NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022
Journal of the National Comprehensive Cancer Network
2022 - Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer
Journal of Thoracic and Cardiovascular Surgery
2022 - Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review
CA A Cancer Journal for Clinicians
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Dana Dominguez
City Of Hope National Medical Center
Swetha Thiruvengadam, MD
City Of Hope National Medical Center
Yuman Fong, MD
City Of Hope National Medical Center
Ravi Salgia, MD, PhD
City Of Hope National Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”